Warner Chilcott, a Rockaway, N.J.-based drug company focused on women's healthcare and dermatology, priced 70.6 million common shares at $15 per share (below $17-$19 range), for an IPO take of approximately $1.06 billion. It plans to trade on the Nasdaq under ticker symbol WCRX, while Goldman Sachs served as lead underwriter. The company was taken […]